Intravesical gemcitabine for non-muscle invasive bladder cancer - Wikidata - wikimedia - TriplyDB

Intravesical gemcitabine for non-muscle invasive bladder cancer

Intravesical gemcitabine for non-muscle invasive bladder cancer

http://www.wikidata.org/entity/Q24203884

about

Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis High-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG Shortage Treatment options in non-muscle-invasive bladder cancer after BCG failure Searching ClinicalTrials.gov and the International Clinical Trials Registry Platform to inform systematic reviews: what are the optimal search approaches?Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity.The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guérin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis

P2860

Q26471299-C8E084FD-DC1C-4D4E-BAB0-6BF5B9F88359 Q26739003-8C8E112C-E49D-43EC-A96E-BB4FFFF61E32 Q26775977-C7AD4643-31D4-47E4-8012-7ECD6E931BF7 Q33825252-9CD080C3-C812-47C9-BAFD-D720078965BC Q46075170-D570685D-C1BC-45F0-9A14-DC91148E4412 Q58795653-C672317E-2435-418F-B874-E37A4817D66A

P2860

Intravesical gemcitabine for non-muscle invasive bladder cancer

http://www.wikidata.org/entity/Q24203884

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Intravesical gemcitabine for non-muscle invasive bladder cancer

@ast

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en-gb

Intravesical gemcitabine for non-muscle invasive bladder cancer

@nl

type

label

Intravesical gemcitabine for non-muscle invasive bladder cancer

@ast

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en-gb

Intravesical gemcitabine for non-muscle invasive bladder cancer

@nl

prefLabel

Intravesical gemcitabine for non-muscle invasive bladder cancer

@ast

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en-gb

Intravesical gemcitabine for non-muscle invasive bladder cancer

@nl

P1433

Q24203884-6EFEA362-1423-409E-9D6D-14E8637207B9

P1476

Q24203884-47DEDE0E-0C13-4E30-8E63-AB1C3678124D

P2093

Q24203884-0F01024A-83E5-48DD-AF10-FB42853EB238

Q24203884-1E88BE2A-0DEC-42D0-9EC9-2923D39F9D7D

Q24203884-675533FB-0135-4DD1-A61C-18CDA4BCC8CE

Q24203884-711BC6C6-8FAD-415D-A8C3-78E5A7CF1989

Q24203884-C88CBED0-97CE-4551-A669-DE8F66364678

Q24203884-D1B8D1E9-10E5-4540-9AFA-B540197A21F2

P2860

Q24203884-011E46F5-F51F-440B-A009-9CD87231BFE1

Q24203884-1747446E-5C85-4AEA-AF9F-289A19461CBD

Q24203884-1941E172-76F4-4F00-8E45-E776BCBEE2A3

Q24203884-3166DDF1-E968-4C58-BD04-A67C9E2C8E56

Q24203884-32D023A8-D915-40E6-946E-03A1F801E89A

Q24203884-47F82D5B-FE67-4E5E-AA56-8F1CEA00BFEA

Q24203884-4B56465C-3988-4D4B-8CB0-F9E66A260B00

Q24203884-516A6360-BBE1-416E-9A91-FE758E2DB5AC

Q24203884-56A1FE8E-D67C-4BB9-8541-76782B07B1A3

Q24203884-5A43936C-1D9D-4408-8332-45B77D57F016

P31

Q24203884-72B55C3C-B6DE-41A7-8CC8-8D3DDFD9C5C1

Q24203884-d385804e-6be8-49c2-ace2-f7bf3d1e307c

P3181

Q24203884-5BD245AA-D8F7-449D-AC52-DAD04480B64F

P356

Q24203884-6F56A1AA-79C5-402B-A8CC-5E01E3E2CAD8

P577

Q24203884-2BC71A4A-2B8E-447B-8EEE-0D1F915FCE50

P698

Q24203884-3C0F41C1-EAA7-4881-9992-7348CA160C51

P3181

P356

14651858.CD009294.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Intravesical gemcitabine for non-muscle invasive bladder cancer

@en

P2093

Anne Cleves

http://www.w3.org/2001/XMLSchema#string

Gabriel Jones

http://www.w3.org/2001/XMLSchema#string

Howard G Kynaston

http://www.w3.org/2001/XMLSchema#string

Malcolm Mason

http://www.w3.org/2001/XMLSchema#string

Mike Shelley

http://www.w3.org/2001/XMLSchema#string

Timothy J Wilt

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder.

Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

Cellular pharmacology of gemcitabine.

Evaluation and follow-up strategies for superficial bladder cancer.

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.

The effects of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin in superficial bladder cancer: a preliminary study.

Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study.

P31

scholarly article

P3181

3771640

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD009294.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22259002

http://www.w3.org/2001/XMLSchema#string